Prime Medicine shares were 9.2% lower, at $3.90, after the company said the Cystic Fibrosis Foundation has agreed to provide it with up to $24 million in additional funding--including a $6 million ...

From my colleague Drew Joseph: Ahead of an advisory committee meeting Thursday focused on GSK’s multiple myeloma drug Blenrep, the FDA pointed to concerns about the high rates of eye issues that have ...

As financial pressures mount and adjacent markets become saturated and/or highly regulated, a growing number of health systems are rethinking the geographic boundaries of traditional mergers and ...

BETHESDA, Md. (July 16, 2025) – Today, the Cystic Fibrosis Foundation announced an additional investment of up to $24 million ...

Expanded funding builds on the initial agreement to accelerate development of Prime Editors for Cystic Fibrosis (CF) -- ...

Suffice to say that health care’s transition to AI will be incremental. Emerging technologies need time to mature, and the short-term needs of health care still outweigh long-term gains. In the ...

Trump’s Nobel Peace Prize nomination sparks global attention. Dive into the details of his recognition and the process behind ...

If you purchase an independently reviewed product or service through a link on our website, SheKnows may receive an affiliate ...

Prime Medicine, Inc. achieved strong early data in CGD with PM359, surpassing efficacy thresholds. Click here to find out why ...

A Prime subscription is good for more than free shipping. Perks like cheaper gas, exclusive deals and discounts on groceries ...

This shift follows the announcement of initial positive data from the Phase 1/2 clinical trial of PM359 in Chronic ...

A major accreditation application deadline looms on Aug. 1 if the planned BYU School of Medicine wants to reach its aggressive goal for admitting its first students.